U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q/A
(Mark One)
x | Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
for the quarterly period ended March 31, 2002 |
¨ | Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
for the transition period from to |
Commission File Number
001-08402
IRVINE SENSORS CORPORATION
(Exact Name of Registrant as Specified in Its Charter)
Delaware | 33-0280334 | |
(State or other Jurisdiction of Incorporation or Organization) | (I.R.S. Employer Identification No.) |
3001 Redhill Avenue, Costa Mesa, California 92626
(Address of Principal Executive Offices)
(714) 549-8211
(Registrant’s Telephone Number, Including Area Code)
Indicate by check whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes X No
As of September 30, 2002, there were 7,033,686 shares of common stock outstanding.
EXPLANATORY NOTE
Irvine Sensors Corporation is hereby amending its Form 10-Q for the interim periods ended March 31, 2002 in response to the SEC’s comments to conform to various “Plain English” and presentation updates of a more recent Registration Statement on Form S-3. No financial changes have been made to the previously reported Consolidated Balance Sheet and Consolidated Results of Operations for the periods presented. Except as expressly stated in this filing, all information contained herein is as of the date of the original filing of this report.
2
PART I – FINANCIAL INFORMATION
Item 1. Financial Statements
IRVINE SENSORS CORPORATION
CONSOLIDATED BALANCE SHEETS
March 31, 2002 | September 30, 2001 | |||||||
(Unaudited) | ||||||||
Assets | ||||||||
Current Assets: | ||||||||
Cash and cash equivalents | $ | 285,100 | $ | 380,200 | ||||
Marketable securities | – | 156,600 | ||||||
Restricted cash | 434,900 | 400,000 | ||||||
Accounts receivable, net of allowances of $57,300 and $57,700, respectively | 1,645,000 | 2,685,900 | ||||||
Inventory | 1,391,600 | 1,114,200 | ||||||
Employee advances | 185,000 | 216,900 | ||||||
Other current assets | 85,400 | 70,400 | ||||||
Total current assets | 4,027,000 | 5,024,200 | ||||||
Equipment, furniture and fixtures, net | 5,220,200 | 5,542,700 | ||||||
Other assets, net | 615,450 | 574,750 | ||||||
$ | 9,862,650 | $ | 11,141,650 | |||||
Liabilities and Stockholders’ Equity | ||||||||
Current Liabilities: | ||||||||
Accounts payable | $ | 2,617,000 | $ | 2,427,600 | ||||
Accrued expenses | 1,951,800 | 1,764,600 | ||||||
Accrued loss on contracts | 772,300 | 921,200 | ||||||
Customer advances | 54,600 | 151,500 | ||||||
Line of credit | 298,900 | 200,000 | ||||||
Short term notes payable, net of discount of $14,300 | 85,700 | – | ||||||
Capital lease obligations – current portion | 104,500 | 228,200 | ||||||
Total current liabilities | 5,884,800 | 5,693,100 | ||||||
Capital lease obligations | 70,400 | 180,300 | ||||||
Minority interest in consolidated subsidiaries | 508,900 | 579,300 | ||||||
Total liabilities | 6,464,100 | 6,452,700 | ||||||
Commitments and contingencies | – | – | ||||||
Stockholders’ Equity: | ||||||||
Preferred stock, $0.01 par value, 500,000 shares authorized; | ||||||||
Series B Convertible Cumulative Preferred, 4,300 shares outstanding; aggregate liquidation preference of $64,500 | 25 | 25 | ||||||
Series C Convertible Cumulative Preferred, 2,300 shares outstanding; aggregate liquidation preference of $33,000 | 25 | 25 | ||||||
Common stock, $0.01 par value, 80,000,000 shares authorized; 5,558,000 and 3,305,300 shares issued and outstanding | 55,600 | 33,100 | ||||||
Common stock warrants and unit warrants; 572,600 and 223,250 warrants outstanding | – | – | ||||||
Prepaid employee stock bonus plan contribution | (246,700 | ) | _ | |||||
Paid-in capital | 99,829,800 | 97,220,300 | ||||||
Accumulated deficit | (96,240,200 | ) | (92,564,500 | ) | ||||
Total stockholders’ equity | 3,398,550 | 4,688,950 | ||||||
$ | 9,862,650 | $ | 11,141,650 | |||||
See Accompanying Condensed Notes to Consolidated Financial Statements.
3
IRVINE SENSORS CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
13 Weeks Ended | 26 Weeks Ended | |||||||||||||||
March 31, 2002 | April 1, 2001 | March 31, 2002 | April 1, 2001 | |||||||||||||
Revenues: | ||||||||||||||||
Contract research and development | $ | 1,121,600 | $ | 796,000 | $ | 2,742,800 | $ | 1,496,000 | ||||||||
Product sales | 1,179,500 | 1,761,800 | 2,055,800 | 3,004,800 | ||||||||||||
Total revenues | 2,301,100 | 2,557,800 | 4,798,600 | 4,500,800 | ||||||||||||
Cost and expenses: | ||||||||||||||||
Cost of contract revenues | 784,800 | 619,700 | 2,046,000 | 1,127,900 | ||||||||||||
Cost of product sales | 975,700 | 1,852,100 | 1,698,300 | 2,890,100 | ||||||||||||
General and administrative expense | 1,677,500 | 2,986,800 | 3,686,000 | 6,230,900 | ||||||||||||
Research and development expense | 336,000 | 1,748,800 | 1,072,400 | 3,790,300 | ||||||||||||
3,774,000 | 7,207,400 | 8,502,700 | 14,039,200 | |||||||||||||
Loss from operations | (1,472,900 | ) | (4,649,600 | ) | (3,704,100 | ) | (9,538,400 | ) | ||||||||
Interest expense | (17,200 | ) | (35,100 | ) | (28,800 | ) | (67,600 | ) | ||||||||
Interest income | 3,800 | 40,400 | 6,800 | 142,100 | ||||||||||||
Loss from continuing operations before minority interest and provision for income taxes | (1,486,300 | ) | (4,644,300 | ) | (3,726,100 | ) | (9,463,900 | ) | ||||||||
Minority interest in loss of subsidiaries | 35,200 | 171,400 | 70,400 | 273,300 | ||||||||||||
Provision for income taxes | (15,200 | ) | – | (20,000 | ) | (4,000 | ) | |||||||||
Loss from continuing operations | (1,466,300 | ) | (4,472,900 | ) | (3,675,700 | ) | (9,194,600 | ) | ||||||||
Discontinued operations: | ||||||||||||||||
Loss from operations of discontinued subsidiary | – | (1,060,800 | ) | – | (2,406,100 | ) | ||||||||||
Net loss | $ | (1,466,300 | ) | $ | (5,533,700 | ) | $ | (3,675,700 | ) | $ | (11,600,700 | ) | ||||
Basic and diluted loss per share: | ||||||||||||||||
Loss from continuing operations | $ | (0.28 | ) | $ | (1.90 | ) | $ | (0.75 | ) | $ | (3.91 | ) | ||||
Loss from discontinued operations | – | (0.45 | ) | – | (1.02 | ) | ||||||||||
Net loss per common share | $ | (0.28 | ) | $ | (2.35 | ) | $ | (0.75 | ) | $ | (4.93 | ) | ||||
Weighted average number of shares outstanding | 5,319,600 | 2,353,700 | 4,911,300 | 2,353,600 | ||||||||||||
See Accompanying Condensed Notes to Consolidated Financial Statements.
4
IRVINE SENSORS CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
26 Weeks Ended | ||||||||
March 31, 2002 | April 1, 2001 | |||||||
Cash flows from operating activities: | ||||||||
Loss from continuing operations | $ | (3,675,700 | ) | $ | (9,194,600 | ) | ||
Adjustments to reconcile loss from continuing operations to net cash used in operating activities: | ||||||||
Depreciation and amortization | 688,600 | 644,100 | ||||||
Noncash compensation | 6,700 | 865,000 | ||||||
Unrealized gain on marketable securities | (300 | ) | (21,800 | ) | ||||
Noncash employee retirement plan contribution | 353,300 | 505,400 | ||||||
Minority interest in net loss of subsidiaries | (70,400 | ) | (273,300 | ) | ||||
Decrease in accounts receivable | 1,040,900 | 329,300 | ||||||
Increase in inventory | (277,400 | ) | (895,400 | ) | ||||
Write-off of employee advances | 42,100 | – | ||||||
Increase in other current assets | (15,000 | ) | (81,700 | ) | ||||
Increase in accounts payable and accrued expenses | 597,500 | 2,189,500 | ||||||
Decrease in accrued loss on contracts | (148,900 | ) | (91,300 | ) | ||||
Increase (decrease) in customer advances | (96,900 | ) | 80,000 | |||||
Total adjustments | 2,120,200 | 3,249,800 | ||||||
Net cash used in operating activities | (1,555,500 | ) | (5,944,800 | ) | ||||
Cash flows from investing activities: | ||||||||
Proceeds from sales of marketable securities | 156,900 | 1,250,000 | ||||||
Increase in restricted cash | (34,900 | ) | – | |||||
Capital facilities and equipment expenditures | (335,600 | ) | (2,326,600 | ) | ||||
Acquisition of other assets | (68,700 | ) | (111,300 | ) | ||||
Capitalized software | – | (179,300 | ) | |||||
Purchase of marketable securities | – | (150,000 | ) | |||||
Net cash used in investing activities | (282,300 | ) | (1,517,200 | ) | ||||
Cash flows from financing activities: | ||||||||
Proceeds from issuance of common stock and common stock warrants | 1,677,100 | 1,306,100 | ||||||
Proceeds from line of credit | 348,900 | – | ||||||
Payments on line of credit | (250,000 | ) | – | |||||
Proceeds from notes payable | 100,000 | – | ||||||
Principal payments of capital leases | (123,100 | ) | (179,300 | ) | ||||
Employee advances | (10,200 | ) | – | |||||
Sale of minority interest in subsidiary | – | 641,700 | ||||||
Proceeds from options and warrants exercised | – | 1,866,900 | ||||||
Net cash provided by financing activities | 1,742,700 | 3,635,400 | ||||||
Net cash used in discontinued operations | – | (1,511,400 | ) | |||||
Net decrease in cash and cash equivalents | (95,100 | ) | (5,338,000 | ) | ||||
Cash and cash equivalents at beginning of period | 380,200 | 7,630,900 | ||||||
Cash and cash equivalents at end of period | $ | 285,100 | $ | 2,292,900 | ||||
Noninvesting and financing activities | ||||||||
Equipment financed with capital leases | $ | 2,500 | $ | 137,500 | ||||
Common stock issued to retire indebtedness | $ | 333,900 | – |
See Accompanying Condensed Notes to Consolidated Financial Statements.
5
IRVINE SENSORS CORPORATION
CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Note 1 – General
The information contained in the following Condensed Notes to Consolidated Financial Statements is condensed from that which would appear in the annual consolidated financial statements. The accompanying unaudited condensed consolidated financial statements do not include certain footnotes and other financial presentations normally required under generally accepted accounting principles. Accordingly, the consolidated financial statements included herein should be reviewed in conjunction with the consolidated financial statements and related notes thereto contained in the Annual Report on Form 10-K of Irvine Sensors Corporation (the “Company”) for the year ended September 30, 2001. It should be understood that accounting measurements at interim dates inherently involve greater reliance on estimates than at year-end. The results of operations for the interim periods presented are not necessarily indicative of the results expected for the entire year.
The consolidated financial information as of March 31, 2002 and April 1, 2001 included herein is unaudited but includes all normal recurring adjustments which, in the opinion of management of the Company, are necessary to present fairly the consolidated financial position of the Company at March 31, 2002, the results of its operations for the 26-week periods ended March 31, 2002 and April 1, 2001, and its cash flows for the 26-week periods ended March 31, 2002 and April 1, 2001.
The consolidated financial statements include the accounts of Irvine Sensors Corporation (“ISC”) and its subsidiaries, Novalog, Inc. (“Novalog”), MicroSensors, Inc. (“MSI”), RedHawk Vision, Inc. (“RedHawk”), iNetWorks Corporation (“iNetWorks”), 3D Microelectronics, Inc. and 3D Microsystems, Inc. All significant intercompany transactions and accounts have been eliminated in the consolidation. Silicon Film was treated as a discontinued operation in 2001 due to its bankruptcy filing.
Note 2 – Common Stock
During the quarter ended December 30, 2001, the Company sold 300,000 common stock units to investors pursuant to its shelf registration statement on Form S-3 which was declared effective in May 2001, generating net proceeds of $300,000. Each common stock unit consisted of (a) one share of common stock of the Company, (b) one five-year warrant to purchase one share of common stock of the Company at an exercise price of $2.19 per share, and (c) one five-year warrant to purchase one share of common stock of iNetWorks Corporation, a subsidiary of the Company, at an exercise price of $0.10 per share. Pursuant to its shelf registration statement, during the first fiscal quarter of 2002, the Company also issued 660,000 shares of common stock to investors generating net proceeds of $817,000, and issued 198,500 shares of its common stock to two creditors in consideration for the cancellation and retirement of $216,400 of existing indebtedness of the Company. During the 13-week period ended March 31, 2002, the Company issued 4,000 shares of its common stock pursuant to an agreement settling a dispute regarding the Company’s guarantee of an obligation of a former subsidiary.
During the 13-week period ended December 30, 2001, the Company issued an aggregate of 194,300 shares of its common stock pursuant to the Company’s 2001 Compensation Plan, which included (a) 162,200 shares issued to employees of the Company in consideration for the cancellation of $184,200 of compensation obligations of the Company and (b) 32,100 shares of its common stock to consultants in consideration for the cancellation of $37,500 of existing indebtedness of the Company. During the 13-week period ended December 30, 2001, the Company received a total of $302,200 of net proceeds from stock subscriptions under the 2001 Compensation Plan. During the quarter ended March 31, 2002, the
6
Company issued an additional 415,910 shares of common stock pursuant to the Company’s 2001 Compensation Plan, which included (a) 397,910 shares issued to employees of the Company in consideration for the cancellation and retirement of $433,300 of compensation obligations of the Company and (b) 18,000 shares of its common stock to a consultant in consideration for the cancellation of $18,000 of existing indebtedness of the Company.
Note 3 – Stock Option Plans and Employee Retirement Plan
In October 2001, the Board of Directors adopted the 2001 Non-Qualified Option Plan, pursuant to which options to purchase an aggregate of 1,500,000 shares of common stock may be granted to attract and retain employees and directors. The terms of the 2001 Non-Qualified Plan are similar to the 2001 Qualified Stock Option Plan; however, only non-statutory options may be issued under the 2001 Non-Qualified Option Plan.
In October 2001, the Board of Directors authorized a contribution of $600,000 to the Company’s retirement plan, the Employee Stock Bonus Plan (“ESB Plan”), which represented a contribution for the fiscal year ending September 29, 2002. In October 2001, the Company issued 480,000 shares of common stock to the ESB Plan to satisfy this contribution for fiscal year 2002. At March 31, 2002, the unamortized prepaid ESB Plan contribution of $246,700 has been recorded as a prepaid Employee Stock Bonus Plan contribution in equity and will be amortized over the remaining quarters of fiscal year 2002.
Note 4 – Marketable Securities and Cash Equivalents
The Company’s marketable securities consist of investments in short-term, government-backed securities and commercial paper. The Company determines proper classification of investments at the time of purchase and re-evaluates such designations at each balance sheet date. All marketable securities are classified as held-to-maturity and are stated at amortized cost. Unrealized gains are included in interest income in the Company’s statements of operations.
For purposes of the statements of cash flows, the Company considers all highly liquid debt instruments purchased with a maturity of three months or less to be cash equivalents.
Note 5 – Inventories, Net
Inventories, net consist of the following:
March 31, 2002 | September 30, 2001 | ||||||
(Unaudited | ) | ||||||
Work in process | $ | 1,328,400 | $ | 892,700 | |||
Finished goods | 63,200 | 221,500 | |||||
Total | $ | 1,391,600 | $ | 1,114,200 | |||
Inventories have been presented above net of reserves for excess and obsolete inventories of approximately $8,197,100 and $8,183,500 at March 31, 2002 and September 30, 2001, respectively.
7
Note 6 – Short-Term Debt Instruments
Novalog, a 95% subsidiary of the Company, has a revolving credit line of up to $400,000, bearing interest at a rate of five percent above the prime rate. The credit line is collateralized by a $400,000 certificate of deposit that is recorded as restricted cash on the consolidated balance sheet. The balance of the restricted cash is attributable to the Company’s deposit on its executive life insurance. There was $298,900 of unpaid principal and interest due on this revolving credit line at March 31, 2002.
In March 2002, the Company borrowed $100,000 pursuant to promissory notes payable in May 2002 from two investors, one of whom is a director of the Company. The promissory notes bear no interest, but are partially secured by receivables pursuant to a specific contract. In consideration of the issuance of the notes, investors received an aggregate of 50,000 warrants to purchase the Company’s common stock at an exercise price of $1.20 per share. The warrants are exerciseable nine months from the issuance of the notes payable, have a term of nine months thereafter and are callable by the Company if the stock issuable from the warrants has been registered and the Company’s stock has traded over $2.00 per share for 10 consecutive trading days. The fair value of the warrants of $21,000 has been recorded as a discount to the related notes payable and is being amortized over the term of the notes of 75 days. Subsequent to March 31, 2002, the Company borrowed an additional $100,000 payable in June 2002, with comparable terms from a different investor.
Note 7 – Reportable Segments
The Company’s operating segments are distinct business units operating in different industries, except the Corporate Headquarters segment, which includes the activities of the other segments. Each segment is separately managed, with separate marketing and distribution systems. The Company’s seven operating segments are Advanced Technology Division (“ATD”), Novalog, Microelectronics Products Division (“MPD”), MSI, RedHawk, iNetWorks and Corporate Headquarters. All operating segments except MPD meet the criteria for reportable segments disclosure as of March 31, 2002. Since no other operating segments would be included with MPD in a nonspecific category, the Company has included MPD as a reportable operating segment. ATD derives most of its revenues from research and development contracts funded primarily by governmental agencies. Novalog designs, develops and sells proprietary integrated circuits (“ICs”) and related products for use in wireless infrared communications. MPD designs, develops and sells stacked 3D microelectronics for use in a variety of systems applications. MSI develops and sells proprietary micromachined sensors and related electronics. iNetWorks is focused on commercializing Irvine Sensors’ proprietary technology for high-speed telecommunications and Internet routers, including the SuperRouter. Corporate Headquarters provides accounting, inventory control and management consulting services to the consolidated subsidiaries. Corporate revenue consists of charges to the subsidiaries for these services and corporate assets consist of loans to subsidiaries and goodwill for reacquisition of subsidiary stock.
The accounting policies used to develop segment information correspond to those described in the summary of significant accounting policies. Segment loss is based on loss from operations before income taxes and minority interest in loss of subsidiaries.
8
The following information about the Company’s seven business segments is for the 26-week period ended March 31, 2002:
ATD | Novalog | MSI | MPD | iNetWorks | RedHawk Vision | Corporate Headquarters | Totals | |||||||||||||||||||||||||
Revenues from external customers | $ | 2,742,800 | $ | 977,100 | $ | 379,100 | $ | 683,700 | $ | – | $ | 15,900 | $ | – | $ | 4,798,600 | ||||||||||||||||
Interest income | – | 4,300 | – | – | – | – | 2,500 | 6,800 | ||||||||||||||||||||||||
Interest expense | 8,600 | 2,900 | 1,800 | 900 | – | – | 14,600 | 28,800 | ||||||||||||||||||||||||
Depreciation and amortization | 399,500 | 27,000 | 103,100 | 29,700 | 200 | 15,200 | 113,900 | 688,600 | ||||||||||||||||||||||||
Segment operating loss | (1,048,400 | ) | (483,200 | ) | (584,000 | ) | (465,800 | ) | (224,000 | ) | (152,300 | ) | (768,400 | ) | (3,726,100 | ) | ||||||||||||||||
Segment assets | 6,901,700 | 1,807,200 | 703,000 | 345,250 | 5,200 | 100,300 | 20,945,000 | 30,807,650 | ||||||||||||||||||||||||
Expenditures for segment assets | 345,000 | 15,400 | 16,100 | 22,300 | – | – | 200 | 399,000 | ||||||||||||||||||||||||
Reconciliation to Consolidated Amounts | ||||||||||||||||||||||||||||||||
Assets | ||||||||||||||||||||||||||||||||
Total assets for reportable segments | 30,807,650 | |||||||||||||||||||||||||||||||
Elimination of intersegment assets | (20,945,000 | ) | ||||||||||||||||||||||||||||||
Total consolidated assets | $ | 9,862,650 | ||||||||||||||||||||||||||||||
The following information about the Company’s seven business segments is for the 13-week period ended March 31, 2002:
ATD | Novalog | MSI | MPD | iNetWorks | RedHawk Vision | Corporate Headquarters | Totals | |||||||||||||||||||||||||
Revenues from external customers | $ | 1,121,600 | $ | 583,700 | $ | 368,400 | $ | 220,700 | $ | – | $ | 6,700 | $ | – | $ | 2,301,100 | ||||||||||||||||
Interest income | – | 1,800 | – | – | – | – | 2,000 | 3,800 | ||||||||||||||||||||||||
Interest expense | 6,500 | 1,200 | 400 | 800 | – | – | 8,300 | 17,200 | ||||||||||||||||||||||||
Depreciation and amortization | 207,300 | 13,700 | 50,800 | 14,400 | 100 | 7,600 | 56,300 | 350,200 | ||||||||||||||||||||||||
Segment operating loss | (357,600 | ) | (293,200 | ) | (92,800 | ) | (266,900 | ) | (113,500 | ) | (119,800 | ) | (242,500 | ) | (1,486,300 | ) | ||||||||||||||||
Expenditures for segment assets | 231,600 | 8,900 | 3,600 | 13,200 | – | – | – | 257,300 |
9
After giving effect to the deconsolidation of Silicon Film, the Company had the following four reportable segments as of April 1, 2001: ATD, Novalog, MSI and Corporate Headquarters. The following information about the four segments is for the 26-week period ended April 1, 2001.
ATD | Novalog | MSI | Corporate Headquarters | Other | Totals | |||||||||||||||||||
Revenues from external customers | $ | 1,496,000 | $ | 2,763,200 | $ | 15,600 | $ | – | $ | 226,000 | $ | 4,500,800 | ||||||||||||
Interest income | – | 17,700 | – | 100,800 | 23,600 | 142,100 | ||||||||||||||||||
Interest expense | 35,000 | – | 2,900 | 26,000 | 3,700 | 67,600 | ||||||||||||||||||
Depreciation and amortization | 317,200 | 29,500 | 89,800 | 81,500 | 126,100 | 644,100 | ||||||||||||||||||
Segment operating loss | (3,237,500 | ) | (201,400 | ) | (1,881,700 | ) | (1,717,200 | ) | (2,426,100 | ) | (9,463,900 | ) | ||||||||||||
Segment assets | 6,913,200 | 3,464,600 | 721,900 | 26,860,700 | 1,096,250 | 39,056,650 | ||||||||||||||||||
Expenditures for segment assets | 1,686,800 | 34,200 | 62,700 | 706,000 | 250,600 | ) | 2,740,300 | |||||||||||||||||
Reconciliation to Consolidated Amounts | ||||||||||||||||||||||||
Assets | ||||||||||||||||||||||||
Total assets for reportable segments | 39,056,650 | |||||||||||||||||||||||
Elimination of intersegment assets | (26,860,700 | ) | ||||||||||||||||||||||
Total consolidated assets | $ | 12,195,950 | ||||||||||||||||||||||
The following information about the four segments is for the 13-week period ended April 1, 2001.
ATD | Novalog | MSI | Corporate Headquarters | Other | Totals | |||||||||||||||||||
Revenues from external customers | $ | 796,000 | $ | 1,659,700 | $ | 8,500 | $ | – | $ | 93,600 | $ | 2,557,800 | ||||||||||||
Interest income | – | 6,800 | – | 13,000 | 20,600 | 40,400 | ||||||||||||||||||
Interest expense | 19,800 | – | 700 | 12,900 | 1,700 | 35,100 | ||||||||||||||||||
Depreciation and amortization | 135,900 | 14,100 | 48,400 | 78,500 | 65,000 | 341,900 | ||||||||||||||||||
Segment operating loss | (1,681,400 | ) | (62,800 | ) | (853,300 | ) | (374,600 | ) | (1,672,200 | ) | (4,644,300 | ) | ||||||||||||
Expenditures for segment assets | 717,000 | 26,900 | 40,300 | 422,500 | 137,300 | 1,344,000 |
Note 8 – Commitments and Contingencies
A class action in the form of several lawsuits was served against the Company and five of its present and former officers and directors in March 2002. The class action purports to seek damages on behalf of a class of stockholders who purchased shares of Irvine Sensors’ stock in reliance on allegedly false statements regarding the prospects for the EFS-1 product being developed by Silicon Film Technologies, Inc., a former subsidiary of the Company. The Company believes that those lawsuits are without merit and intends to defend the action vigorously.
10
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
This Report contains forward-looking statements regarding Irvine Sensors Corporation and its subsidiaries (collectively, the “Company”), which include, but are not limited to, statements concerning projected revenues, expenses, gross profit and income, market acceptance of the Company’s products, the competitive nature of the Company’s business and its markets, the success and timing of new product introductions and commercialization of the Company’s technologies, the need for additional capital and the outcome of pending litigation. These forward-looking statements are based on the Company’s current expectations, estimates and projections about the Company’s industry, management’s beliefs, and certain assumptions made by management. Words such as “anticipates,” “expects,” “intends,” “plans,” “predicts,” “potential,” “believes,” “seeks,” “estimates,” “should,” “may,” “will” and variations of these words or similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions that are difficult to predict. Therefore, the Company’s actual results could differ materially and adversely from those expressed in any forward-looking statements as a result of various factors. Such factors include, but are not limited to the following:
• | the ability of the Company to secure additional research and development contracts; |
• | the ability of the Company to introduce new products, gain broad market acceptance for such products and ramp-up manufacturing in a timely manner; |
• | the pace at which new markets develop; |
• | the response of competitors, many of whom are bigger and better financed than the Company; |
• | the Company’s ability to successfully execute its business plan and control costs and expenses; |
• | the availability of additional financing; |
• | the Company’s ability to establish strategic partnerships to develop the business of its subsidiaries; |
• | the depressed market capitalization of the Company; |
• | general economic and political instability; and |
• | those additional factors which are listed under the section “Risk Factors” at the end of Item 2 of this Report. |
The Company does not undertake any obligation to revise or update publicly any forward-looking statements for any reason. Additional information on various risk and uncertainties potentially affecting the Company’s results are discussed below and are contained in publicly filed disclosures available through the Securities and Exchange Commission EDGAR database (http://www.sec.gov) or from the Company’s Investor Relations Department.
Overview
The Company currently has seven operating segments: ATD, Novalog, MPD, MSI, RedHawk, iNetWorks and Corporate Headquarters. Each segment is separately managed, with separate marketing and distribution systems. Historically, ISC has made significant investments to fund research and development for its operating subsidiaries. To date, other than Novalog, none of ISC’s subsidiaries have contributed material revenues or earnings to the Company’s consolidated results of operations. During fiscal 2001, ISC adopted a policy to significantly reduce its investments in its subsidiaries for the near future. As a result, the subsidiaries may need to seek independent funding or partner with third parties to finance their operations.
11
Results of Operations
Revenues
The Company’s contract revenue for the 13-week and 26 week periods ended March 31, 2002 was $1,121,600 and $2,742,800, respectively, which represented an increase of $325,600, or 41%, and $1,246,800, or 83%, respectively, for the 13-week and 26-week periods ended April 1, 2001. The increase in contract revenue is primarily attributable to the receipt of new funded contracts allowing the Company to allocate more resources to the performance of contract backlog during the current period as opposed to internal research and development during the comparable period of fiscal 2001.
The Company’s product sales decreased $582,300 or 33% and $949,000 or 32% for the 13 and 26-week periods ended March 31, 2002, respectively, compared to the 13-week and 26-week periods ended April 1, 2001. This reduction primarily reflects a decrease in Novalog sales attributable to the decline in the sales of Palm Computing, a major customer, which was partially offset by increased sales of MPD products.
Total contract and product sales revenues for the 13-week period ended March 31, 2002 were $2,301,100, a decrease of $256,700 or 10% compared to the $2,557,800 realized in the 13-week period ended April 1, 2001. Total contract and product sales revenues for the 26-week period ended March 31, 2002 were $4,798,600, an increase of $297,800 or 7% compared to the $4,500,800 of total revenues in the 26-week period ended April 1, 2001. Based on notices of pending government contract awards, the Company expects that its contract revenue will continue to represent a higher percentage of its total revenue compared to revenue from product sales for the balance of fiscal 2002. However, there can be assurance that the Company will win the pending awards.
Cost of Revenues
The Company’s cost of contract revenue for the 13-week period ended March 31, 2002 was $784,800, which represented an increase of $165,100, or approximately 27%, from $619,700 for the 13-week period ended April 1, 2001. However, the cost of contract revenues as a percentage of contract revenues decreased to 70% in the 13-week period ended March 31, 2002 from 78% in the 13-week period ended April 1, 2001. For the 26-week period ended March 31, 2002, the cost of contract revenues was $2,046,000, an increase of $918,100 or 81% from $1,127,900 for the 26-week period ended April 1, 2001. The cost of contract revenues as a percentage of contract revenues was 75% during the 26-week period ended March 31, 2002 as compared to 75% for the 26-week period ended April 1, 2001. The increase in costs of contract revenues for both the 13-week and 26-week periods was primarily attributable to the additional costs incurred to generate the increased revenues from funded contracts, many of which are of a cost-plus-fixed fee nature. The improved margin on contract revenues in the 13-week period ended March 31, 2002, reflects lower labor costs due to salary reductions during the period.
The Company’s cost of product sales for the 13-weeks ended March 31, 2002 was $975,700, a decrease of $876,400, or 47%, from $1,852,100 for the 13-week period ended April 1, 2001. The cost of product sales for the 26-week period ended March 31, 2002 was $1,698,300, a decrease of $1,191,800, or 41%, from $2,890,100 for the 26-week period ended April 1, 2001. The 13-week and 26-week reductions were directly attributable to a decline in the volume of products sold during those periods in fiscal 2002 versus the comparable periods of fiscal 2001. The cost of product sales as a percentage of product sales decreased from 105% to 83% in the 13-week period ended March 31, 2002 compared to the 13-week period ended April 1, 2001, and decreased from 96% to 83% in the 26-week period ended March 31, 2002 versus April 1, 2001. The increase in gross margins during the 13-week and 26-week periods
12
reflects a different product mixture in the current periods incorporating a greater contribution from higher margin stacked memory products sold by MPD.
Research and Development Expense
The Company’s research and development expense for the 13-week period ended March 31, 2002 was $336,000, which represented a decrease of $1,412,800, or approximately 81%, from $1,748,800 for the 13-week period ended April 1, 2001. For the 26-week period ended March 31, 2002, research and development expenses declined $2,717,900, or 72%, to $1,072,400 from $3,790,300 for the 26-week period ended April 1, 2001. Research and development expense represented approximately 15% of the Company’s total revenue for the 13-week period ended March 31, 2002, compared to approximately 68% of the Company’s total revenue for the 13-weeks ended April 1, 2001. For the 26-week period ended March 31, 2002, research and development expense represented approximately 22% of total revenue versus 84% for the 26-week period ended April 1, 2001. These substantial decreases in both absolute amount and percentage of total revenue are attributable to a shift of resources from internally funded research, particularly to support the business plans of subsidiaries, and an increased focus on third-party contract-funded work, which results in less unreimbursed research and development expense. The Company currently intends to continue focusing its efforts and resources more on third party contract-related work than on internal research and development. Accordingly, the Company does not believe that its research and development expense will increase significantly, either in absolute amount or as a percentage of total revenue, in the near future.
General and Administrative Expense
General and administrative expense for the 13-week and 26-week periods ended March 31, 2002 was $1,677,500, or 73% of total revenue, and $3,686,000, or 77% of total revenue, respectively. These figures compared to $2,986,800 and $6,230,900, respectively, for the comparable 13-week and 26-week periods ended April 1, 2001. The current fiscal year figures were reductions of $1,309,300, or 44%, and $2,544,900, or 41%, respectively, compared to the prior year 13-week and 26-week periods ended April 1, 2001. This decrease was largely attributable to substantial across-the-board salary and expense reductions in the Company’s parent and subsidiary operations during the first half of fiscal 2002 versus the comparable period of fiscal 2001. Management believes that salary and expense reductions will also favorably impact general and administrative expense in the second half of fiscal 2002.
Interest Expense/Interest Income
Interest expense net for the 13-week period ended March 31, 2002 was $17,200, which represented a decrease of $17,900 from the 13-week period ended April 1, 2001. Interest expense net for the 26-week period ended March 31, 2002 was $28,800, a decrease of $38,800 from the 26-week period ended April 1, 2001. These decreases were primarily due to the retirement of capital lease obligations.
Interest income for the 13-week period ended March 31, 2002 was $3,800, which represented a decrease of $36,400 from the 13-week period ended April 1, 2001. Interest income for the 26-week period ended March 31, 2002 was $6,800, a decrease of $135,300 from the 26-week period ended April 1, 2001. These reductions were largely due to lower average interest rates and cash balances during the 13-week and 26-week periods in fiscal 2002 compared to the corresponding periods in fiscal 2001, which still reflected cash balances from a large financing completed in August 2000.
13
Liquidity and Capital Resources
At March 31, 2002, the Company had consolidated cash and cash equivalents of $285,100, which represents a decrease of $95,100 from $380,200 as of September 30, 2001. The net cash used in operating activities was $1,555,500 during the first 26-week period of fiscal 2002. The primary use of cash was to fund the loss from the Company’s continuing operations.
The Company used a net of $282,300 of cash in investing activities during the first 26 week period of fiscal 2002, consisting of $68,700 invested primarily in patents, $335,600 invested in capital facilities and equipment, a $34,900 increase in restricted cash which was offset by $156,900 in proceeds from sales of marketable securities. Except for lease agreements for the acquisition of capital equipment, the Company had no other material capital commitments as of March 31, 2002.
During the first 26 week period of fiscal 2002, the Company generated net cash of $1,742,700 from financing activities. Cash provided by financing activities included $300,000 from the sale of common stock units, $816,900 from the sale of common stock, and $587,900 from stock subscriptions received. Cash provided by financing activities also included $100,000 of aggregate principal amount of non-interest bearing promissory notes issued in March 2002. The notes mature 75 days from issuance. In lieu of interest, the Company issued to the promissory note investors warrants to purchase up to 50,000 shares of the Company’s common stock at a price per share of $1.20. The warrants become exercisable nine months after issuance and expire 18 months after issuance. During the first 26 week period of fiscal 2002, the Company’s subsidiary, Novalog, borrowed $348,900 from and made payments of $250,000 on its revolving credit line. The credit line is for borrowings up to $400,000, and is secured by restricted cash of $400,000. As of March 31, 2002, $298,900 was outstanding under this credit line.
Net cash provided by equity and minority interest transactions was reduced by principal payments on capital leases payable of $123,100 during the 26-week period ended March 30, 2002. As a result of net losses during the first 26 weeks of fiscal 2002, partially offset by cash provided by financing activities, the Company’s consolidated working capital deficit increased from $668,900 at September 30, 2001 to $1,857,800 at March 31, 2002. The bulk of this increased working capital deficit is due to pre-contractual activity undertaken by the Company to support expected new U.S. government contracts. Approximately $640,000 of this pre-contractual activity was funded and invoiced pursuant to a contract modification received after March 31, 2002. Management believes that the balance of such pre-contractual work will be substantially funded during the remainder of fiscal 2002, although there is no guarantee that the Company will receive such funding. Furthermore, the timing of any such reimbursement is subject to risks and delays. While management believes that its government-funded contract business and its stacked-memory business will continue to grow during the remainder of fiscal 2002, it may take several months for the Company to receive payment for receivables generated by anticipated new contract-related work. Accordingly, management continues to believe that it will need to either obtain interim financing of such receivables or raise at least an additional $750,000 to fund its operations in the near future. While the Company believes that it will be able to obtain such financing, and that its projected operating results and such financing will meet its cash requirements for the immediate future; there can be no assurance that the Company will be able to secure any required financing to continue its operations.
Contracts with government agencies may be suspended or terminated by the government at any time, subject to certain conditions. Similar termination provisions are typically included in agreements with prime contractors. Since its inception, the Company has experienced such termination of its contracts on three occasions. There is no assurance the Company will not experience suspensions or terminations in the future. Any such termination, if material, could cause a disruption of the Company’s
14
revenue stream, adversely affect the Company’s results of operations and could result in employee layoffs. At March 31, 2002, the Company’s funded backlog was approximately $2.2 million compared to approximately $2.1 million at September 30, 2001 and $4.0 million at April 1, 2001.
The Company has reserved 415,700 shares of common stock for issuance to its employees and consultants under its 2001 Compensation Plan as of March 31, 2002. During the first 26-week period of fiscal 2002, the Company issued 610,210 shares of common stock to its employees under this plan as consideration for the cancellation of outstanding compensation obligations to its employees and two consultants. The Company currently intends to continue issuing shares of its common stock to employees and consultants under this plan.
Risk Factors
Our future operating results are highly uncertain. Before deciding to invest in Irvine Sensors or to maintain or increase your investment, you should carefully consider the risks described below, in addition to the other information contained in this report, our Annual Report on Form 10-K, as amended, our Quarterly Reports on Form 10-Q, as amended, and in our other filings with the Commission, including any subsequent reports filed on Forms 10-K, 10-Q and 8-K. The risks and uncertainties described below are not the only ones that we face. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also affect our business and results of operations. If any of these risks actually occur, our business, financial condition or results of operations could be seriously harmed. In that event, the market price for our common stock could decline and you may lose all or part of your investment.
We have historically generated substantial losses, which, if continued, could make it difficult to fund our operations or successfully execute our business plan, and could adversely affect our stock price. We experienced net losses of $14.6 million for the year ended September 30, 2001, $15.0 million for the year ended October 1, 2000 and $9.1 million for the year ended October 3, 1999. We also incurred net losses of approximately $5.4 million for the 39 weeks ended June 30, 2002. In recent years, much of our losses were incurred as a result of our significant investments in our development stage operating subsidiaries. While we have significantly reduced our investment in subsidiaries, we anticipate that we will continue to generate net losses in the future and cannot assure you that we will be able to achieve or sustain profitability on a quarterly or annual basis in the future. In addition, because a large portion of our expenses are fixed, we generally are unable to reduce expenses significantly in the short-term to compensate for any unexpected delay or decrease in anticipated revenues. As a result, we may continue to experience net losses, which will make it difficult to fund our operations and achieve our business plan, and could cause the market price of our common stock to decline.
We will likely need to raise additional capital in the future, and additional funds may not be available on terms that are acceptable to us, or at all. We have generated significant net losses in recent periods, and experienced negative cash flows from operations in the amount of approximately $10.2 million for the year ended September 30, 2001 and $2.1 million for the 39 weeks ended June 30, 2002. At June 30, 2002, we had consolidated negative working capital of approximately $1.0 million. We cannot guarantee that we will be able to generate sufficient funds from our operations to meet our immediate working capital needs. In addition, our current growth plans require certain equipment, facility and product development expenditures that cannot be funded from cash generated from operations unless and until our current liabilities are substantially retired. Accordingly, we anticipate that we will likely need to raise additional capital to fund our aggregate requirements although the nature, timing and amount of that need is not immediately determinable. We cannot assure you that any additional capital may be available on a timely basis, on acceptable terms, or at all. If we are not able to
15
obtain additional capital, our business, financial condition and results of operations will be materially adversely affected.
Our capital requirements will depend on many factors, including:
• | our ability to control costs; |
• | our ability to commercialize our technologies and achieve broad market acceptance for such technologies; |
• | our ability to procure additional government research and development contracts; |
• | the timing of payments and reimbursements from government and other contracts; |
• | research and development funding requirements and required investments in our subsidiaries; |
• | increased sales and marketing expenses; |
• | technological advancements and competitors’ response to our products; |
• | capital improvements to new and existing facilities; |
• | our relationships with customers and suppliers; and |
• | general economic conditions including the effects of the current economic slowdown and international conflicts. |
If our capital requirements are materially different from those currently planned, we may need additional capital sooner than anticipated. Additional funds may be raised through borrowings, other debt or equity financings, or the divestiture of business units or select assets. If additional funds are raised through the issuance of equity or convertible debt securities, the percentage ownership of our stockholders will be reduced and such securities may have rights, preferences and privileges senior to our common stock. Additional funds may not be available on favorable terms or at all, particularly in view of the significant decline in our market capitalization. If adequate funds are not available on acceptable terms, or at all, we may be unable to finance our operations, develop or enhance our products, expand our sales and marketing programs, take advantage of future opportunities or respond to competitive pressures.
Financing, if available, could result in significant costs to us, even if not consummated. In certain circumstances, it is possible that we or our subsidiaries could experience very substantial transaction costs or break-up fees in connection with efforts to obtain financing. For example, we entered into a non-binding letter of intent related to the possible financing of our iNetWorks subsidiary in 2001 that obligated us to pay $1.0 million to the investor if we had rejected the financing. Although we ultimately were not required to pay this break-up fee, it is not uncommon for prospective investment agreements to contain these contractual provisions. Financings, in general, also require a significant amount of management’s time and can distract us from executing our business plan. Furthermore, the costs and expenses of such financings, including legal fees, can significantly increase our operating expenses.
Our common stock may be delisted from the Nasdaq SmallCap Market if our stock price declines further or if we cannot maintain Nasdaq’s minimum net worth listing requirements. In such case, the market for your shares may be limited, and it may be difficult for you to sell your shares at an acceptable price, if at all. Our common stock is currently listed on the Nasdaq SmallCap Market. Among other requirements, to maintain this listing, our common stock must continue to trade above $1.00 per share. In July 2001, our stock had failed to meet this criterion for over 30 consecutive trading
16
days. Therefore, in accordance with Marketplace Rule 4310(c)(8)(B), we were notified by Nasdaq that we had 90 calendar days or until October 2001 to regain compliance with this Rule by reestablishing a sales price of $1.00 per share or greater for ten consecutive trading days. To regain compliance, we sought and received approval from our stockholders to effectuate a 1-for-20 reverse split of our common stock that became effective in September 2001, resulting in recompliance by the Nasdaq deadline. However, subsequent to the reverse split, our stock has, at various times, traded close to the $1.00 per share minimum standard, and we cannot assure you that the sales price will continue to meet Nasdaq minimum standards. At September 30, 2002, the closing sales price of our common stock was $1.25 per share.
In addition to the price requirement, in the absence of sustained profitability, we must also meet at least one of the two following additional standards to maintain our Nasdaq listing: (1) maintenance of tangible net worth at $2 million or greater or stockholders’ equity at $2.5 million or greater, or (2) maintenance of a market capitalization figure in excess of $35 million as measured by market prices for trades executed on Nasdaq. In July 2001, Nasdaq notified us that we were deficient with respect to both these additional standards based on our balance sheet as of April 1, 2001. In August 2001, we were advised by Nasdaq that, based on updated information, we had reestablished compliance with the $35 million market capitalization standard. However, the subsequent decline in the price of our common stock resulted in another deficiency notice from Nasdaq in August 2001. In December 2001, we were notified by Nasdaq that we had reestablished compliance under the additional compliance requirements. This recompliance was based on improvements in our stockholders’ equity resulting from the net gain of approximately $0.9 million realized from the discontinuance of operations of our Silicon Film subsidiary in September 2001. Although we are currently in compliance with Nasdaq’s listing maintenance requirements, we cannot assure you that we will be able to maintain our compliance with these requirements in the future. If we fail to meet these or other listing requirements, our common stock could be delisted, which would eliminate the primary market for your shares of common stock. As a result, you may not be able to sell your shares at an acceptable price, if at all.
If we are delisted from the Nasdaq SmallCap Market, your ability to sell your shares of our stock would also be limited by the penny stock restrictions, which could further limit the marketability of your shares. If our common stock is delisted, it would come within the definition of “penny stock” as defined in the Securities Exchange Act of 1934, as amended, and would be covered by Rule 15g-9 of that Act. That Rule imposes additional sales practice requirements on broker-dealers who sell securities to persons other than established customers and accredited investors. For transactions covered by Rule 15g-9, the broker-dealer must make a special suitability determination for the purchaser and receive the purchaser’s written agreement to the transaction prior to the sale. Consequently, Rule 15g-9, if it were to become applicable, would affect the ability or willingness of broker-dealers to sell our securities and accordingly would affect the ability of stockholders to sell their securities in the public market. These additional procedures could also limit our ability to raise additional capital in the future.
We are defendants in a class-action stockholders lawsuit, an unfavorable outcome of which could harm our ability to continue our operations, and the defense of which is also substantially increasing our on-going operating expenses. We have been sued by certain stockholders who allege that we made false and misleading statements about the prospects of our Silicon Film subsidiary during the period January 6, 2000 to September 15, 2001, inclusive. The complaint asserts claims for violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Securities and Exchange Commission Rule 10b-5, and seeks damages of an unspecified amount. We believe that the class action is without merit and have retained counsel to vigorously defend against the lawsuit. This lawsuit has resulted in a substantial increase in our legal costs that has more than offset our recent improvements in our core operating results. In addition, the outcome of any litigation is inherently uncertain, and we may
17
not be able to satisfy an unfavorable outcome in this litigation, which could cause us to discontinue operations.
If we are not able to commercialize our technology, we may not be able to increase our revenues or achieve or sustain profitability. Since commencing operations, we have developed technology, principally under government research contracts, for various defense-based applications. Contract research and development accounted for approximately 50% of our revenues for the year ended September 30, 2001 and represented approximately 65% of our revenues for the 39 weeks ended June 30, 2002. However, since our margins on government contracts are generally limited, and our revenues from such contracts are tied to government budget cycles and influenced by numerous political and economic factors beyond our control, and are subject to our ability to win additional contracts, our long-term prospects of realizing significant returns from our technology will likely also require penetration of commercial markets. In prior years we have made significant investments to commercialize our technologies without significant success. These efforts included the purchase and later shut down of the IBM cubing line, the formation of the Novalog, MSI, RedHawk and iNetWorks subsidiaries and the development of various stacked-memory products intended for military, aerospace and commercial markets. While these changes have developed new revenue sources, they have not yet resulted in consolidated profitability to date, and a majority of our consolidated revenues for the year ended September 30, 2001 and for the 39 weeks ended June 30, 2002 were still generated from contract research and development. Only our Novalog subsidiary has experienced periods of profitability, and that subsidiary is not currently profitable due to the decline in the sales of palm-top computers, the largest user of Novalog’s products. We cannot assure you that any of our present and contemplated future products will achieve broad market acceptance in commercial marketplaces, and if they do not, our business, results of operations and financial condition will be materially and adversely affected.
Significant sales of our common stock in the public market will cause our stock price to fall. As of June 30, 2002, we had approximately 6.9 million shares of common stock outstanding, of which approximately 4.8 million shares were freely tradable, other than restrictions imposed upon our affiliates. An additional 1.0 million shares are subject to contractual restrictions on trading, but become freely tradable between October 2002 and November 2002 when the contractual restrictions expire. The average daily trading volume of our shares in July 2002 was only approximately 15,800 shares. The freely tradable shares, along with the contractually restricted shares, are significantly greater in number than the daily average trading volume of our shares. If the selling stockholders, or the holders of the freely tradable shares, were to sell a significant amount of our common stock in the public market, the market price of our common stock would likely be significantly adversely affected.
From time to time, we may elect to retire obligations of our subsidiaries with cash payments or through the issuance of shares of our common stock, resulting in dilution to our existing stockholders and a decrease in our stock price. In June 2002, we issued approximately 279,000 shares of our common stock, representing approximately 4% of our shares outstanding, to retire $500,000 of debt incurred by our iNetWorks subsidiary. We elected to enter into this agreement to preserve a strategic working relationship with the iNetWorks debt holder. We have also settled certain disputed obligations of our former Silicon Film subsidiary with cash payments and may elect to settle obligations of other subsidiaries in the future should business considerations warrant such an action. Although we are not required to retire the obligations of our subsidiaries, we may make such business decisions again, which could have a dilutive impact to our existing stockholders or could negatively impact our available capital. Furthermore, when and if the recipients of any such shares elect to sell them in the public market, the market price of our common stock could likely be materially and adversely affected.
18
Our equity and voting interests in our subsidiaries were significantly diluted in the past as a result of private placements, and further financings could cause us to lose control of our subsidiaries. We have historically funded the operations of our subsidiaries with equity financings. The financing of our Novalog and RedHawk subsidiaries to date have involved significant private sales of common stock of those subsidiaries representing approximately 32% of the outstanding capital stock of Novalog and approximately 30% of the outstanding capital stock of RedHawk, generating net proceeds to Novalog of approximately $4.1 million and approximately $581,000 for RedHawk. While we repurchased approximately 28% of the common stock of Novalog from minority investors during fiscal years 1998 and 1999, we do not currently have sufficient discretionary capital to repurchase additional shares of Novalog or any other subsidiary. As a result of our decision to significantly reduce our expenditures related to our subsidiaries and increase our emphasis on government contracts, our subsidiaries have substantially reduced their operations. In order to continue their developmental activities, our subsidiaries would have to sell additional equity interests to finance at least some portion of their business plans. Such additional financings may not be available on acceptable terms, it at all. Even if financing becomes available, our ability to enjoy the benefits of any potential increase in value on the part of our subsidiaries can be greatly reduced by third-party investments. Additional financings by our subsidiaries will result in a reduction in our equity interests in the subsidiaries and reduced control of our subsidiaries. Significant third-party investment in our subsidiaries will likely result in third-party investors receiving subsidiary board representation and/or protective covenants that could further reduce our control over the day-to-day operations and strategic direction of our subsidiaries. Third-party financings of subsidiaries will also inherently complicate our fiduciary and contractual obligations and could leave us more vulnerable to costly and uncertain litigation in the future, which could have a material adverse effect on our business, financial condition and results of operations.
Our government-funded research and development business depends on a limited number of customers, and if any of these customers terminate or reduce their contracts with us, or if we cannot obtain additional government contracts in the future, our revenues will decline and our results of operations will be adversely affected. In the fiscal year ended September 30, 2001, all of our revenues from government agencies were derived from three governmental agencies, the U.S. Navy, the U.S. Air Force and the U.S. Army. The Army and the Air Force each accounted for approximately 5% of our consolidated revenues, but the U.S. Navy accounted for approximately 32% of our consolidated revenues. In addition, approximately 9% of our consolidated revenues were derived from a limited number of prime government contractors. Although we ultimately plan to shift our focus to include the commercialization of our technology, we expect to continue to be dependent upon research and development contracts with federal agencies and their contractors for a substantial portion of our revenues for the foreseeable future. This dependency on a few contract sources increases the risks of disruption in this area of our business that could adversely affect our consolidated revenues and results of operations.
Because we currently depend on government contracts and subcontracts, we face additional risks related to contracting with the federal government, including federal budget issues and fixed price contracts. General political and economic conditions, which cannot be accurately predicted, directly and indirectly affect the quantity and allocation of expenditures by federal agencies. Even the timing of incremental funding commitments to existing, but partially funded, contracts can be affected by these factors. Therefore, cutbacks or re-allocations in the federal budget could have a material adverse impact on our results of operations as long as research and development contracts remain an important element of our business. Obtaining government contracts may also involve long purchase and payment cycles, competitive bidding, qualification requirements, delays or changes in funding, budgetary constraints, political agendas, extensive specification development and price negotiations and milestone requirements. Each government agency also maintains its own rules and regulations with which we must
19
comply and which can vary significantly among agencies. Governmental agencies also often retain some portion of fees payable upon completion of a project and collection of these fees may be delayed for several months or even years, in some instances. In addition, an increasing number of our government contracts are fixed price contracts which may prevent us from recovering costs incurred in excess of its budgeted costs. Fixed price contracts require us to estimate the total project cost based on preliminary projections of the project’s requirements. The financial viability of any given project depends in large part on our ability to estimate such costs accurately and complete the project on a timely basis. In the 39-week period ended June 30, 2002, we completed fixed-price contracts with an aggregate value of $846,000. We experienced approximately $60,000 in overruns on those contracts, representing approximately 7% of the aggregate funded amount. While those overruns were largely discretionary in nature, we may not be able to achieve or improve upon this performance in the future since each contract has its own unique technical and schedule risks. In the event our actual costs exceed the fixed contractual cost, we will not be able to recover the excess costs. Some of our government contracts are also subject to termination or renegotiation at the convenience of the government, which could result in a large decline in revenue in any given quarter. Although government contracts have provisions providing for the reimbursement of costs associated with termination, the termination of a material contract at a time when our Company’s funded backlog does not permit redeployment of our staff could result in reductions of employees. In April 1999, we experienced the termination of one of our contracts, but this termination did not result in the non-recovery of costs or layoff of employees. We have had to reduce our staff from time-to-time because of fluctuations in our funded government contract base. In addition, the timing of payments from government contracts is also subject to significant fluctuation and potential delay, depending on the government agency involved. Any such delay could result in a temporary shortage in our working capital. Because over 50% of our consolidated revenues in the year ended September 30, 2001 were derived directly of indirectly from government contractors, these risks can significantly affect our business, results of operations and financial condition.
We also depend on a limited number of non-government customers. The loss of any such customer could seriously impact our consolidated revenues and harm our business. Our existing product sales have largely been derived from our Novalog subsidiary, which is heavily dependent upon sales to a limited number of original equipment manufacturers, two of which, Manufacturer’s Service Limited and Citizen Electronics Co. Ltd, accounted for approximately 12% and 10%, respectively, of our consolidated revenues. Both of these OEMs are suppliers to Palm Computing. A majority of Novalog’s product sales in fiscal 2000 and fiscal 2001 were derived from sales for use in Palm’s products. As such, the decline in Palm’s business during fiscal 2001 was a primary cause of the 29% decline in Novalog’s sales for that period and the approximately 60% decline in Novalog’s sales for the first 39 weeks of fiscal 2002 as compared to the comparable period in fiscal 2001. Novalog has had to significantly downsize its operations to reflect this decline in business of its primary customer. The planned business models of our MicroSensors and iNetWorks subsidiaries have similar expected dependencies on a limited number of OEM customers. Disruption of any of these relationships could materially and adversely affect our consolidated revenues and results of operations.
If we are not able to obtain market acceptance of our new products, our revenues and results of operations will be adversely affected. We focus on markets that are emerging in nature and potentially subject to rapid growth. Market reaction to new products in these circumstances can be difficult to predict. Many of our planned products incorporate our chip stacking technologies that have not yet achieved broad market acceptance. We cannot assure you that our present or future products will achieve market acceptance on a sustained basis. In addition, due to our historical focus on research and development, we have a limited history of competing in the intensely competitive commercial electronics industry. As such, we cannot assure you that we will successfully develop, manufacture and market additional commercial product lines or that such product lines will be accepted in the commercial
20
marketplace. If we are not successful, our ability to generate revenues and our business, financial condition and results of operations will be adversely affected.
If we are not able to adequately protect or enforce our patent or other intellectual property rights, our ability to compete in our target markets could be materially and adversely affected. We believe that our success, and that of our subsidiaries, will depend, in part, on the strength of our existing patent protection and the additional patent protection that we and our subsidiaries may acquire in the future. As of June 30, 2002, Irvine Sensors owned 43 U.S. patents in force and nine foreign patents and has other patent applications pending before the U.S. Patent and Trademark Office as well as various foreign jurisdictions. It is possible that any existing patents or future patents, if any, could be challenged, invalidated or circumvented, and any right granted under these patents may not provide us with meaningful protection from competition. Despite our precautions, it may be possible for a third party to copy or otherwise obtain and use our products, services or technology without authorization, to develop similar technology independently or to design around our patents. In addition we treat technical data as confidential and generally rely on internal nondisclosure safeguards, including confidentiality agreements with employees, and on laws protecting trade secrets, to protect proprietary information. We cannot assure you that these measures will adequately protect the confidentiality of our proprietary information or that others will not independently develop products or technology that are equivalent or superior to ours.
Our ability to exploit our own technologies may be constrained by the rights of third parties who could prevent us from selling our products in certain markets or could require us to obtain costly licenses. Other companies may hold or obtain patents or inventions or may otherwise claim proprietary rights to technology useful or necessary to our business. We cannot predict the extent to which we may be required to seek licenses under such proprietary rights of third parties and the cost or availability of these licenses. While it may be necessary or desirable in the future to obtain licenses relating to one or more proposed products or relating to current or future technologies, we cannot assure you that we will be able to do so on commercially reasonable terms, if at all. If our technology is found to infringe upon the rights of third parties, or if we are unable to gain sufficient rights to use key technologies, , our ability to compete would be harmed and our business, financial condition and results of operations would be materially and adversely affected.
Enforcing and protecting our patents and other proprietary information can be costly. If we are not able to adequately protect or enforce our proprietary information or if we become subject to infringement claims by others, our business, results of operations, and financial condition may be materially adversely affected. We may need to engage in future litigation to enforce our intellectual property rights or the rights of our customers, to protect our trade secrets or to determine the validity and scope of proprietary rights of others, including our customers. We also may need to engage in litigation in the future to enforce our patent rights. In addition, we may receive in the future communications from third parties asserting that our products infringe the proprietary rights of third parties. We cannot assure you that any such claims would not result in protracted and costly litigation. This litigation could result in substantial costs and diversion of our resources and could materially and adversely affect our business, financial condition and results of operations. Furthermore, there is also no assurance that we will have the financial resources to vigorously defend or enforce our patents or other proprietary technology.
Our proprietary information and other intellectual property rights are subject to government use which, in some instances, limits our ability to capitalize on them. Whatever degree of protection, if any, is afforded to us through our patents, proprietary information and other intellectual property, will not extend to government markets that utilize certain segments of our technology. The government has the right to royalty-free use of technologies that we have developed under government contracts, including
21
portions of our stacked circuitry technology. While we are generally free to commercially exploit these government-funded technologies and we may assert our intellectual property rights to seek to block other non-government users of the same, we cannot assure you that we will be successful in our attempts to do so.
We are subject to significant competition that could harm our ability to win new business or attract strategic partnerships and could increase the price pressure on our products. We face strong competition from a wide variety of competitors, including large, multinational semiconductor design firms and aerospace firms. Most of our competitors have considerably greater financial, marketing and technological resources than we or our subsidiaries do, which may make it difficult to win new contracts or to attract strategic partners. This competition has resulted and may continue to result in declining average selling prices for our products. We cannot assure you that we will be able to compete successfully with these companies. Certain of our competitors operate their own fabrication facilities and have longer operating histories and presence in key markets, greater name recognition, larger customer bases and significantly greater financial, sales and marketing, manufacturing, distribution, technical and other resources than us. As a result, these competitors may be able to adapt more quickly to new or emerging technologies and changes in customer requirements. They may also be able to devote greater resources to the promotion and sale of their products. Increased competition has in the past resulted in price reductions, reduced gross margins and loss of market share, and this trend may continue in the future. We cannot assure you that we will be able to continue to compete successfully or that competitive pressures will not materially and adversely affect our business, financial condition and results of operations.
We do not have guaranteed long-term supply relationships with any of our contract manufacturers which could make it difficult to fulfill our backlog in any given quarter and could reduce our revenues in future periods. We extensively rely on contract manufacturers but do not have the financial resources to maintain long-term supply agreements with contract manufacturers or other suppliers. Accordingly, because our contract manufacturers allocate their manufacturing resources in periods of high demand, we face several significant risks, including a lack of adequate supply, potential product shortages and higher prices and limited control over delivery schedules, quality assurance and control, manufacturing yields and production costs. We cannot assure you that we will be able to satisfy our manufacturing needs in the future. Failure to do so will have a material adverse impact on our operations and the amount of products we can ship in any period.
If we cannot adapt to unforeseen technological advances, we may not be able to successfully compete with our competitors.We operate in industries characterized by continuing technological development. Accordingly, we will be required to devote substantial resources to improve already technologically complex products. Many companies in these industries devote considerably greater resources to research and development than we do. Developments by any of these companies could have a materially adverse effect on us if we are not able to keep up with the same developments. Our future success will depend on our ability to successfully adapt to any new technological advances in a timely manner, or at all.
We do not have any long-term employment agreements with any of our key personnel.If we are not able to retain our key personnel, we may not be able to implement our business plan and our results of operations could be materially and adversely affected. We depend to a large extent on the abilities and continued participation of our executive officers and other key employees, particularly John Carson, our president and John Stuart, our chief financial officer. The loss of any key employee could have a material adverse effect on our business. While we have adopted employee stock option plans designed to attract and retain key employees, our stock price has declined in recent periods, and we
22
cannot guarantee that options granted under our plans will be effective in retaining key employees. We do not presently maintain “key man” insurance on any key employees. We believe that, as our activities increase and change in character, additional, experienced personnel will be required to implement our business plan. Competition for such personnel is intense and we cannot assure you that they will be available when required, or that we will have the ability to attract and retain them.
Our stock price has been subject to significant volatility. You may not be able to sell your shares of common stock at or above the price you paid for them. The trading price of our common stock has been subject to wide fluctuations in the past. Since January 2000, the common stock has traded at prices as low as $0.77 per share and as high as $375.00 per share, after giving effect to the 1-for-20 reverse stock split in September 2001. We may not be able to increase or sustain the current market price of our common stock in the future. As such, you may not be able to resell your shares of common stock at or above the price you paid for them. The market price of the common stock could continue to fluctuate in the future in response to various factors, including, but not limited to:
• | quarterly variations in operating results; |
• | our ability to control costs and improve cash flow; |
• | announcements of technological innovations or new products by us or our competitors; |
• | changes in investor perceptions; |
• | new products or product enhancements by us or our competitors; and |
• | changes in earnings estimates or investment recommendations by securities analysts. |
The stock market in general has continued to experience volatility, which has particularly affected the market price of equity securities of many high technology companies. This volatility has often been unrelated to the operating performance of these companies. These broad market fluctuations may adversely affect the market price of our common stock. In the past, companies that have experienced volatility in the market price of their securities have been the subject of securities class action litigation. We are currently subject to class action lawsuits that could result in substantial losses and divert management’s attention and resources from other matters.
Our international operations are subject to many inherent risks, any of which may adversely affect our business, financial condition and results of operations. Approximately 10% of our consolidated total revenues in the year ended September 30, 2001 and approximately 5% for the 39 weeks ended June 30, 2002 was derived from sales outside the United States. In the future, we intend to continue to expand our international business activities. International operations are subject to many inherent risks that may adversely effect our business, financial condition and operating results, including:
• | political, social and economic instability; |
• | trade restrictions; |
• | the imposition of governmental controls; |
• | exposure to different legal standards, particularly with respect to intellectual property; |
• | burdens of complying with a variety of foreign laws; |
• | import and export license requirements and restrictions of the United States and each other country in which we operate; |
23
• | unexpected changes in regulatory requirements; |
• | foreign technical standards; |
• | fluctuations in currency exchange rates; |
• | difficulties in managing foreign operations and collecting receivables from foreign entities; and |
• | potentially adverse tax consequences. |
We may be subject to additional risks. The risks and uncertainties described above are not the only ones facing our company. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also adversely affect our business operations.
24
PART II
OTHER INFORMATION
Item 1. Legal Proceedings
A class action in the form of several lawsuits was served against the Company and five of its present and former officers and directors in March 2002. The class action purports to seek damages on behalf of a class of stockholders who purchased shares of Irvine Sensors’ stock in reliance on allegedly false statements regarding the prospects for the EFS-1 product being developed by Silicon Film Technologies, Inc., a former subsidiary of the Company. The Company believes that those lawsuits are without merit and intends to defend the action vigorously.
Item 2. Changes in Securities and Use of Proceeds.
(c) In March 2002, the Company issued $100,000 aggregate principal amount of non-interest bearing promissory notes to two private investors, including Wolfgang Seidel, one of the Company’s outside directors. The notes mature 75 days from issuance. In connection with this loan, the Company also issued to the investors warrants to purchase up to 50,000 shares of the Company’s common stock at a price per share of $1.20. The warrants become exercisable nine months after issuance and expire 18 months after issuance. Mr. Seidel received half of these warrants. The Company believes the issuance of the warrants was exempt from registration under the 1933 Securities Act (the “Act”) pursuant to the private placement exemption available under Section 4(2) of the Act.
On March 18, 2002, the Company issued 4,000 shares of its common stock to Delphi Engineering Group as part of a settlement agreement of a dispute in the amount of $4,600 regarding the Company’s guarantee of a $180,000 obligation of a former subsidiary. The Company believes the issuance of these shares was exempt from registration under the Act pursuant to the private placement exemption available under Section 4(2) of the Act.
Item 6. Exhibits and Reports on Form 8-K
(a) Exhibits.
10.1 | * | Contract No. F30602-02-C-0030, by and between the Company and the Air Force Research Laboratory. | |
10.2 | * | Contract No. DAAB07-02-C-F608, by and between the Company and the U.S. Army. | |
10.3 | * | Contract No. N3998-02-C-4510, by and between the Company and the Department of Defense. | |
10.4 | * | Form of Note and Warrant issued by the Company. | |
99.1 | Periodic Report Certification of the Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | ||
* | Previously filed by the Registrant with this report on May 3, 2002. |
(b) Reports on Form 8-K.
Form 8-K filed on January 10, 2002, posting a period message from Robert G. Richards, Chief Executive Officer.
25
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Date: October 8, 2002 | Irvine Sensors Corporation (Registrant) | |||||||
By: | /s/ John J. Stuart, Jr. | |||||||
John J. Stuart, Jr. Chief Financial Officer (Principal Accounting Officer) |
CERTIFICATIONS
I, Robert G. Richards, certify that:
1. I have reviewed this periodic report on Form 10-Q/A of Irvine Sensors Corporation;
2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this annual report; and
3. Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this annual report.
Date: October 8, 2002
/s/ Robert G. Richards |
Robert G. Richards, Chief Executive Officer (Principal Executive Officer) |
26
I, John J. Stuart, Jr., certify that:
1. I have reviewed this periodic report on Form 10-Q/A of Irvine Sensors Corporation;
2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this annual report; and
3. Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this annual report.
Date: October 8, 2002
/s/ John J. Stuart, Jr. |
John J. Stuart, Jr., Chief Financial Officer (Principal Financial and Chief Accounting Officer) |
27